Jain AB et al. |
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. |
1990 |
Transplant. Proc. |
pmid:1689900
|
Fung JJ et al. |
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. |
1990 |
Transplant. Proc. |
pmid:1689901
|
Zeevi A et al. |
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1689902
|
Imventarza O et al. |
Renal transplantation in baboons under FK 506. |
1990 |
Transplant. Proc. |
pmid:1689903
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Maki N et al. |
Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. |
1990 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1695378
|
Doe SE et al. |
Early effects of the immunosuppressive drug FK-506 on signal transduction in lymphocytes. |
1990 |
Biochem. Soc. Trans. |
pmid:1695581
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Granelli-Piperno A et al. |
The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. |
1990 |
J. Exp. Med. |
pmid:1701825
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Takai K et al. |
Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry. |
1990 |
Clin. Exp. Immunol. |
pmid:1702372
|
Okubo Y et al. |
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. |
1990 |
Clin. Exp. Immunol. |
pmid:1702373
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Gschwendt M et al. |
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo. |
1989 |
Immunobiology |
pmid:2471685
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Tocci MJ et al. |
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. |
1989 |
J. Immunol. |
pmid:2472451
|
Leonard DK et al. |
Toxicity of FK-506 in human fetal pancreas. |
1989 |
Diabetes |
pmid:2463195
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|